Physician profile
Dennis S Gray
NPI 1942202288
$13,886.68
in general payments reported to CMS, 2019-2025
38 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,393 · 2020: $1,451 · 2021: $2,588 · 2022: $1,884 · 2023: $2,208 · 2024: $2,565 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,570.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,030.93 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,842.19 | 2021-2025 | |
| Pfizer INC. | $1,314.02 | 2019-2025 | |
| Novo Nordisk INC | $1,153.75 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $765.47 | 2019-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $719.05 | 2019-2024 | Veozah |
| Lilly USA, LLC | $615.25 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $560.01 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Janssen Pharmaceuticals, INC | $543.38 | 2019-2024 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $534.08 | 2021-2025 | |
| Glaxosmithkline, LLC. | $381.58 | 2019-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $330.73 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $307.89 | 2019-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $284.20 | 2019-2025 | |
| Axsome Therapeutics, INC. | $255.18 | 2024-2025 | Auvelity |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.